BPH Procedures Market Comprehensive Review of its Top Companies, Investment Trend, Growthby Pramod Kumar Digital Marketing Professional
According to the National Institute of Health, it has been estimated
that around 14 million men in the U.S. had symptoms suggestive of BPH, which
can affect 50% of men aged between 51 and 60 years of age, and up to 90% of men
aged more than 80 years. With 50% of men getting affected with BPH, there is a
consequent increase in the BPH procedures.
As per the findings of the research, surgical procedure held the
largest share in the global BPH procedures, primarily due to increasing
prevalence of BPH disorders. The number of laser based procedure is expected to
register fastest growth during the forecast period since these procedures are
as effective as surgical procedures and reduce the hospital stay time.
Hospitals held the largest share of the number of BPH procedures performed,
based on the end user. Ambulatory surgical centers are expected to witness the
highest inflow of BPH patients for treatment during the forecast period, due to
development of technologically advanced BPH procedures and rising prevalence of
BPH disorders leading to the growth in the number of patients treated in the
ambulatory surgical centers.
Sample at: https://www.psmarketresearch.com/market-analysis/benign-prostatic-hyperplasia-procedures/report-sample
Geographically, Europe accounted for the largest number of BPH
procedures done in 2016. Growing ageing population, lower cost of BPH treatment
as compared to the U.S., high healthcare spending, and technological
advancements in the field of urological procedures technology are some of the
factors driving the growth of the BPH procedures in the Europe. France, Germany
and the U.K. are expected to be the most promising countries for the growth in
number of the BPH procedures. In June 2016, National Institute of Health and
Care Excellence (NICE) approved GreenLight XPS laser treatment for the
treatment of BPH. NICE added that the widespread adoption of the procedure
could save the National Health Services (NHS) an estimated $4.3 million (£3
million) a year. Asia-Pacific is expected to witness the high number of BPH
procedures performed during the forecast period, owing to the rising prevalence
of BPH disorders, increasing disposable income, aging population, and growing
efforts to increase awareness about advanced BPH treatment procedures.
Make Enquiry Before
Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=benign-prostatic-hyperplasia-procedures
Key players are in the process of introducing new advanced products
for BPH treatment procedures. For instance, in
May 2016, Olympus Corporation (Olympus), announced the launch of USFDA cleared
Plasma-OvalButton, an addition to the company’s Plasma Loops and electrodes
product portfolio that utilizes Olympus’ plasma technology for urologic
procedures, including minimally invasive surgery to reduce benign prostate
In March 2016, Lumenis Ltd. (Lumenis), announced the expansion of its
comprehensive Urology portfolio with the launch of Lumenis Pulse 30H, at the
European Association of Urology Congress, in Munich.
Created on Jun 20th 2019 01:05. Viewed 591 times.